Wakefield Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.41M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $319K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.49M | Buy |
|
|||||
|
2020
Q4 | $2.31M | Sell |
|
|||||
|
2020
Q3 | $2.39M | Sell |
|
|||||
|
2020
Q2 | $2.34M | Sell |
|
|||||
|
2020
Q1 | $2.65M | Buy |
|
|||||
|
2019
Q4 | $2.89M | Sell |
|
|||||
|
2019
Q3 | $2.49M | Sell |
|
|||||
|
2019
Q2 | $2.97M | Sell |
|
|||||
|
2019
Q1 | $3.51M | Buy |
|
|||||
|
2018
Q4 | $3.56M | Buy |
|